| scholarly article | Q13442814 |
| P2093 | author name string | Roneil G Malkani | |
| Trongha X Phan | |||
| P2860 | cites work | Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index | Q21144740 |
| Plasticity of the intrinsic period of the human circadian timing system | Q21144751 | ||
| Sundowning and Circadian Rhythms in Alzheimer’s Disease | Q22241871 | ||
| Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease | Q22251067 | ||
| Alzheimer mechanisms and therapeutic strategies | Q22252311 | ||
| Impact of sleep debt on metabolic and endocrine function | Q23731787 | ||
| Cryptochromes mediate rhythmic repression of the glucocorticoid receptor | Q24299891 | ||
| The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity | Q24317782 | ||
| Amyloid plaque core protein in Alzheimer disease and Down syndrome | Q24568384 | ||
| Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy | Q24604376 | ||
| Obesity and metabolic syndrome in circadian Clock mutant mice | Q24627935 | ||
| Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity | Q24634010 | ||
| Control of sleep and wakefulness | Q24634619 | ||
| Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle | Q24644961 | ||
| Activation of Erk and JNK MAPK pathways by acute swim stress in rat brain regions | Q24791140 | ||
| The amyloid hypothesis of Alzheimer's disease at 25 years | Q26749528 | ||
| Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer's disease | Q26753192 | ||
| The genetic landscape of Alzheimer disease: clinical implications and perspectives | Q26796582 | ||
| Synchrony and desynchrony in circadian clocks: impacts on learning and memory | Q26796708 | ||
| About sleep's role in memory | Q26826833 | ||
| Alzheimer's disease and insulin resistance: translating basic science into clinical applications | Q26996487 | ||
| Amyloid-β diurnal pattern: possible role of sleep in Alzheimer's disease pathogenesis | Q27026835 | ||
| Experimental 'jet lag' inhibits adult neurogenesis and produces long-term cognitive deficits in female hamsters | Q27312894 | ||
| Diminished CRE-Induced Plasticity is Linked to Memory Deficits in Familial Alzheimer's Disease Mice | Q27333843 | ||
| Stress and the HPA axis: role of glucocorticoids in alcohol dependence | Q27693315 | ||
| The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 | ||
| Ocular indicators of Alzheimer's: exploring disease in the retina | Q28078670 | ||
| Melanopsin retinal ganglion cell loss and circadian dysfunction in Alzheimer's disease (Review) | Q28079228 | ||
| Three dimensions of the amyloid hypothesis: time, space and 'wingmen' | Q28082768 | ||
| Stability, precision, and near-24-hour period of the human circadian pacemaker | Q28138096 | ||
| Gene expression of the key enzymes of melatonin synthesis in extrapineal tissues of the rat | Q28187472 | ||
| The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation | Q28189614 | ||
| Melanopsin in cells of origin of the retinohypothalamic tract | Q28205953 | ||
| Phototransduction by retinal ganglion cells that set the circadian clock | Q28217956 | ||
| Stress and disorders of the stress system | Q28247137 | ||
| Neuroinflammation in Alzheimer's disease | Q28259238 | ||
| Molecular components of the mammalian circadian clock | Q28264527 | ||
| Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior | Q28266541 | ||
| Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy | Q28282855 | ||
| The effect of psychosocial stress on sleep: a review of polysomnographic evidence | Q34703523 | ||
| Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer's disease | Q34708307 | ||
| Molecular mechanisms of environmental enrichment: impairments in Akt/GSK3β, neurotrophin-3 and CREB signaling | Q34735544 | ||
| Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. | Q34737994 | ||
| Measuring melatonin in humans. | Q34762973 | ||
| Gastrointestinal melatonin: localization, function, and clinical relevance | Q34978489 | ||
| Circadian disruption and SCN control of energy metabolism | Q34984884 | ||
| Neuronal activity regulates the regional vulnerability to amyloid-β deposition | Q35009626 | ||
| A web of circadian pacemakers | Q35036512 | ||
| Melatonin effects on bone: experimental facts and clinical perspectives | Q35058211 | ||
| The Role of Actigraphy in the Study of Sleep and Circadian Rhythms | Q35128463 | ||
| Circadian clock disruption in neurodegenerative diseases: cause and effect? | Q35128512 | ||
| Blood-brain barrier breakdown in the aging human hippocampus | Q35151019 | ||
| Optogenetic disruption of sleep continuity impairs memory consolidation | Q35164741 | ||
| Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer's disease: results of a randomized, controlled trial | Q35171044 | ||
| Increased fragmentation of sleep-wake cycles in the 5XFAD mouse model of Alzheimer's disease | Q35182808 | ||
| An opportunistic theory of cellular and systems consolidation | Q35242425 | ||
| A time to remember: the role of circadian clocks in learning and memory. | Q35272964 | ||
| Human apoE isoforms differentially regulate brain amyloid-β peptide clearance | Q35334161 | ||
| Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy | Q35590867 | ||
| Circadian Clocks and the Interaction between Stress Axis and Adipose Function. | Q35590973 | ||
| Therapeutic implications of HPA axis abnormalities in Alzheimer's disease: review and update. | Q35607369 | ||
| Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia | Q35607536 | ||
| Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women | Q35630404 | ||
| The stress response neuropeptide CRF increases amyloid-β production by regulating γ-secretase activity | Q35762646 | ||
| Ca2+ -stimulated adenylyl cyclases regulate ERK-dependent activation of MSK1 during fear conditioning | Q35765742 | ||
| Moderate Changes in the Circadian System of Alzheimer's Disease Patients Detected in Their Home Environment | Q35884023 | ||
| Suprachiasmatic neuron numbers and rest-activity circadian rhythms in older humans | Q35889348 | ||
| Circadian and wakefulness-sleep modulation of cognition in humans | Q35895575 | ||
| Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity | Q35973444 | ||
| Weaker circadian activity rhythms are associated with poorer executive function in older women | Q35993665 | ||
| Molecular and evolutionary basis of the cellular stress response | Q36041011 | ||
| The hypothalamic integrator for circadian rhythms | Q36062621 | ||
| Microbiota Diurnal Rhythmicity Programs Host Transcriptome Oscillations | Q36212153 | ||
| Dorsomedial SCN neuronal subpopulations subserve different functions in human dementia | Q41513820 | ||
| Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease | Q41845723 | ||
| Effect of REM sleep deprivation on the antioxidant status in the brain of Wistar rats | Q41949056 | ||
| Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease | Q42002890 | ||
| The diurnal oscillation of MAP (mitogen-activated protein) kinase and adenylyl cyclase activities in the hippocampus depends on the suprachiasmatic nucleus | Q42041247 | ||
| Microbiota modulation counteracts Alzheimer's disease progression influencing neuronal proteolysis and gut hormones plasma levels. | Q42098016 | ||
| Sleep restriction impairs blood-brain barrier function. | Q42212597 | ||
| Chronically restricted sleep leads to depression-like changes in neurotransmitter receptor sensitivity and neuroendocrine stress reactivity in rats | Q42223310 | ||
| Suppression of glymphatic fluid transport in a mouse model of Alzheimer's disease | Q42364356 | ||
| Hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's disease: lack of association between longitudinal and cross-sectional findings | Q42450710 | ||
| Activation of ventrolateral preoptic neurons during sleep | Q42513216 | ||
| Circadian Oscillations within the Hippocampus Support Memory Formation and Persistence. | Q42542785 | ||
| Gamma frequency entrainment attenuates amyloid load and modifies microglia | Q42631490 | ||
| Melatonin reduces hippocampal beta-amyloid generation in rats exposed to chronic intermittent hypoxia | Q42960518 | ||
| Localized cortical thinning in patients with obstructive sleep apnea syndrome | Q43107021 | ||
| Amyloid beta mediates memory formation | Q43155401 | ||
| Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions | Q43163166 | ||
| The suprachiasmatic nucleus generates the diurnal changes in plasma leptin levels | Q43610683 | ||
| Chronic 'jet lag' produces temporal lobe atrophy and spatial cognitive deficits | Q43615609 | ||
| Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. | Q43638880 | ||
| Oxidative damage is the earliest event in Alzheimer disease | Q43696731 | ||
| Afferents to the ventrolateral preoptic nucleus. | Q43875616 | ||
| Midlife psychological stress and risk of dementia: a 35-year longitudinal population study | Q43980650 | ||
| Sleep deprivation decreases superoxide dismutase activity in rat hippocampus and brainstem | Q44094566 | ||
| Hippocampal CRE-mediated gene expression is required for contextual memory formation | Q44170929 | ||
| The polymorphism of CLOCK gene 3111T/C C>T is associated with susceptibility of Alzheimer disease in Chinese population | Q44213884 | ||
| Stress inhibition of melatonin synthesis in the pineal organ of rainbow trout (Oncorhynchus mykiss) is mediated by cortisol. | Q44535923 | ||
| Increased susceptibility to intermittent hypoxia in aging rats: changes in proteasomal activity, neuronal apoptosis and spatial function | Q44570078 | ||
| Polymorphism of CLOCK gene rs 4580704 C > G is associated with susceptibility of Alzheimer's disease in a Chinese population | Q44650658 | ||
| Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease | Q45007608 | ||
| Sleep Loss Promotes Astrocytic Phagocytosis and Microglial Activation in Mouse Cerebral Cortex | Q45009755 | ||
| Circadian variation in stress-evoked increases in plasma corticosterone | Q45157655 | ||
| Elevated basal cortisol level predicts lower hippocampal volume and cognitive decline in Alzheimer's disease. | Q45943592 | ||
| Sleep and Human Aging. | Q46025057 | ||
| Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adults | Q46061056 | ||
| Alzheimer's disease: A matter of blood-brain barrier dysfunction? | Q46165463 | ||
| Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levels | Q46170588 | ||
| Alzheimer's disease and gut microbiota modifications: The long way between preclinical studies and clinical evidence | Q46242741 | ||
| Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation | Q46422756 | ||
| Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases | Q46444429 | ||
| PI3 kinase signaling is required for retrieval and extinction of contextual memory | Q46529350 | ||
| Behavioral and EEG changes in male 5xFAD mice | Q46882725 | ||
| Neuromicrobiology: How Microbes Influence the Brain | Q47268586 | ||
| Effect of sleep on overnight CSF amyloid-β kinetics. | Q47563259 | ||
| Sleep in Alzheimer's Disease - Beyond Amyloid | Q47586083 | ||
| Sleep disturbances increase the risk of dementia: A systematic review and meta-analysis | Q47625482 | ||
| Roles of tau pathology in the locus coeruleus (LC) in age-associated pathophysiology and Alzheimer's disease pathogenesis: Potential strategies to protect the LC against aging | Q47651120 | ||
| Genetic underpinnings in Alzheimer's disease - a review | Q47678652 | ||
| Altered Gut Microbiota in a Mouse Model of Alzheimer's Disease | Q47784335 | ||
| Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease. | Q48022782 | ||
| Sleep deprivation potentiates HPA axis stress reactivity in healthy adults | Q48107412 | ||
| Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype | Q48110773 | ||
| Apolipoprotein E: cholesterol transport protein with expanding role in cell biology | Q28294791 | ||
| Orexin signaling regulates both the hippocampal clock and the circadian oscillation of Alzheimer's disease-risk genes | Q28315261 | ||
| Field measurements of light exposures and circadian disruption in two populations of older adults | Q28392742 | ||
| High-fat diet-induced hyperinsulinemia and tissue-specific insulin resistance in Cry-deficient mice | Q28511606 | ||
| Diurnal expression of functional and clock-related genes throughout the rat HPA axis: system-wide shifts in response to a restricted feeding schedule | Q28572853 | ||
| Melatonin attenuates the focal cerebral ischemic injury by inhibiting the dissociation of pBad from 14-3-3 | Q28576697 | ||
| Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B | Q29012704 | ||
| Alzheimer's disease: the amyloid cascade hypothesis | Q29547160 | ||
| Physiology of microglia | Q29547414 | ||
| Alzheimer's disease is a synaptic failure | Q29547670 | ||
| Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein | Q29547803 | ||
| A two process model of sleep regulation | Q29615631 | ||
| Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders | Q29615839 | ||
| APP processing and synaptic function | Q29615873 | ||
| Interacting molecular loops in the mammalian circadian clock | Q29616206 | ||
| Neural regulation of endocrine and autonomic stress responses | Q29616362 | ||
| The genetics of mammalian circadian order and disorder: implications for physiology and disease | Q29616366 | ||
| Sleep function and synaptic homeostasis | Q29618693 | ||
| Circadian gene expression in individual fibroblasts: cell-autonomous and self-sustained oscillators pass time to daughter cells | Q29619080 | ||
| Hypothalamic regulation of sleep and circadian rhythms | Q29619151 | ||
| The memory function of sleep | Q29619446 | ||
| Neurons containing hypocretin (orexin) project to multiple neuronal systems | Q29619641 | ||
| Sleep drives metabolite clearance from the adult brain | Q29620065 | ||
| Diurnal fluctuations in HPA and neuropeptide Y-ergic systems underlie differences in vulnerability to traumatic stress responses at different zeitgeber times | Q30392032 | ||
| Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine | Q30455458 | ||
| Prostaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models. | Q30634663 | ||
| Anatomical demonstration of the suprachiasmatic nucleus-pineal pathway | Q30657826 | ||
| Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy | Q30996799 | ||
| Bright light therapy and melatonin in motor restless behaviour in dementia: a placebo-controlled study | Q31948981 | ||
| Influence of sleep deprivation and circadian misalignment on cortisol, inflammatory markers, and cytokine balance | Q33593056 | ||
| Melatonin synthesis pathway: circadian regulation of the genes encoding the key enzymes in the chicken pineal gland and retina | Q33696097 | ||
| Targeting psychologic stress signaling pathways in Alzheimer's disease. | Q33820375 | ||
| New insights on the role of microglia in synaptic pruning in health and disease | Q33821505 | ||
| Circadian temperature and melatonin rhythms, sleep, and neurobehavioral function in humans living on a 20-h day. | Q33876449 | ||
| The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. | Q33910875 | ||
| Intermittent hypoxia-induced cognitive deficits are mediated by NADPH oxidase activity in a murine model of sleep apnea | Q33916216 | ||
| Genetic disruption of the core circadian clock impairs hippocampus-dependent memory | Q33928919 | ||
| The tolerability and safety of cholinesterase inhibitors in the treatment of dementia | Q33960410 | ||
| Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup | Q33969633 | ||
| Homeostatic, circadian, and emotional regulation of sleep | Q36299554 | ||
| Concurrent impairments in sleep and memory in amnestic mild cognitive impairment | Q36309134 | ||
| Stress-induced changes in sleep in rodents: models and mechanisms | Q36409134 | ||
| Hippocampal Injections of Oligomeric Amyloid β-peptide (1-42) Induce Selective Working Memory Deficits and Long-lasting Alterations of ERK Signaling Pathway | Q36449089 | ||
| Melanopsin retinal ganglion cell loss in Alzheimer disease | Q36533171 | ||
| The Locus Coeruleus: Essential for Maintaining Cognitive Function and the Aging Brain | Q36600664 | ||
| Circadian Rhythms, Sleep, and Disorders of Aging | Q36731044 | ||
| Increased prevalence of sleep-disordered breathing in adults | Q36805068 | ||
| Disruption of the sleep-wake cycle and diurnal fluctuation of β-amyloid in mice with Alzheimer's disease pathology | Q36845156 | ||
| Increases in cAMP, MAPK activity, and CREB phosphorylation during REM sleep: implications for REM sleep and memory consolidation | Q36846382 | ||
| Sleep quality and preclinical Alzheimer disease | Q36913338 | ||
| Adrenal peripheral clock controls the autonomous circadian rhythm of glucocorticoid by causing rhythmic steroid production. | Q37081710 | ||
| A blood screening test for Alzheimer's disease | Q37085325 | ||
| Melatonin in Alzheimer's disease | Q37091982 | ||
| Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer's disease | Q37116609 | ||
| Stress-induced activity in the locus coeruleus is not sensitive to stressor controllability | Q37335628 | ||
| Complement and microglia mediate early synapse loss in Alzheimer mouse models. | Q37391481 | ||
| Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial. | Q37408523 | ||
| Circadian oscillation of hippocampal MAPK activity and cAmp: implications for memory persistence. | Q37409553 | ||
| Obstructive sleep apnea decreases central nervous system-derived proteins in the cerebrospinal fluid | Q37432083 | ||
| Sleep inertia, sleep homeostatic and circadian influences on higher-order cognitive functions | Q37443329 | ||
| Obstructive sleep apnea and neurocognitive performance: the role of cortisol | Q37530601 | ||
| Phase-dependent resetting of the adrenal clock by ACTH in vitro | Q37629373 | ||
| Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota | Q37631109 | ||
| Role of oxidative stress in the progression of Alzheimer's disease | Q37671458 | ||
| Sleep and Alzheimer disease pathology--a bidirectional relationship | Q37691522 | ||
| Stress and glucocorticoid receptor-dependent mechanisms in long-term memory: from adaptive responses to psychopathologies | Q37691910 | ||
| Sleep state switching | Q37822544 | ||
| Circadian rhythm of adrenal glucocorticoid: its regulation and clinical implications | Q37841817 | ||
| Melatonin as a natural ally against oxidative stress: a physicochemical examination. | Q37900675 | ||
| Stress effects on memory: an update and integration | Q37902769 | ||
| Stress-induced cytokines and neuronal dysfunction in Alzheimer's disease | Q37962276 | ||
| Manipulation of microglial activity as a therapy for Alzheimer's disease | Q38015185 | ||
| The interplay between the intestinal microbiota and the brain | Q38045736 | ||
| The circadian system in Alzheimer's disease: disturbances, mechanisms, and opportunities | Q38070232 | ||
| Aβ-induced degradation of BMAL1 and CBP leads to circadian rhythm disruption in Alzheimer's disease | Q34043803 | ||
| Influences of Dietary and Environmental Stress on Microbial Populations in the Murine Gastrointestinal Tract | Q34105660 | ||
| Serotoninergic and melatoninergic systems are fully expressed in human skin | Q34131016 | ||
| Temperature as a universal resetting cue for mammalian circadian oscillators | Q34143703 | ||
| Sleep is related to neuron numbers in the ventrolateral preoptic/intermediate nucleus in older adults with and without Alzheimer's disease | Q34174946 | ||
| A phase response curve to single bright light pulses in human subjects | Q34193115 | ||
| Effects of age and amyloid deposition on Aβ dynamics in the human central nervous system | Q34215733 | ||
| Increased sleep fragmentation leads to impaired off-line consolidation of motor memories in humans | Q34217726 | ||
| Interaction of stress, corticotropin-releasing factor, arginine vasopressin and behaviour | Q34225879 | ||
| The circadian clock and pathology of the ageing brain | Q34259247 | ||
| Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model | Q34349078 | ||
| Sleep Fragmentation and the Risk of Incident Alzheimer's Disease and Cognitive Decline in Older Persons | Q34354571 | ||
| Increased brain damage after stroke or excitotoxic seizures in melatonin-deficient rats. | Q34409037 | ||
| Circadian rhythm abnormalities in totally blind people: incidence and clinical significance | Q34454699 | ||
| Small molecule modifiers of circadian clocks. | Q34480532 | ||
| Current pharmacotherapy for Alzheimer's disease | Q34484065 | ||
| Evidence for neuroinflammatory and microglial changes in the cerebral response to sleep loss | Q34585839 | ||
| The hypocretins: setting the arousal threshold | Q34623823 | ||
| The sleep-wake cycle and Alzheimer's disease: what do we know? | Q34637928 | ||
| Circadian clock gene expression in brain regions of Alzheimer 's disease patients and control subjects | Q48144848 | ||
| Sleep disturbance is associated with incident dementia and mortality | Q48162950 | ||
| REM sleep loss and recovery regulates blood-brain barrier function | Q48175346 | ||
| Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia | Q48212116 | ||
| Period1 gates the circadian modulation of memory-relevant signaling in mouse hippocampus by regulating the nuclear shuttling of the CREB kinase pP90RSK. | Q48217585 | ||
| Melatonin protects against ischemia and reperfusion-induced oxidative lipid and DNA damage in fetal rat brain | Q48219036 | ||
| Deregulation of hypothalamic-pituitary-adrenal axis functions in an Alzheimer's disease rat model | Q48233777 | ||
| Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia | Q48284990 | ||
| Sleep deprivation impairs contextual fear conditioning and attenuates subsequent behavioural, endocrine and neuronal responses | Q48336877 | ||
| Postmortem tracing reveals the organization of hypothalamic projections of the suprachiasmatic nucleus in the human brain. | Q48380015 | ||
| Sleep deprivation induces brain region-specific decreases in glutathione levels. | Q48381964 | ||
| The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. | Q48453920 | ||
| The circadian rhythm of glucocorticoids is regulated by a gating mechanism residing in the adrenal cortical clock. | Q48454141 | ||
| Hypothalamic-pituitary-adrenal axis activity in obese men with and without sleep apnea: effects of continuous positive airway pressure therapy. | Q48458089 | ||
| Effects of sleep inertia on cognition. | Q48517783 | ||
| Ultradian, circadian, and stress-related hypothalamic-pituitary-adrenal axis activity--a dynamic digital-to-analog modulation. | Q48551759 | ||
| Nighttime insomnia treatment and education for Alzheimer's disease: a randomized, controlled trial. | Q48553398 | ||
| Polysomnographic study of the effect of melatonin on sleep in elderly patients with chronic primary insomnia. | Q48580666 | ||
| Circadian cycling of the mouse liver transcriptome, as revealed by cDNA microarray, is driven by the suprachiasmatic nucleus. | Q48637314 | ||
| Circadian interleukin-6 secretion and quantity and depth of sleep. | Q48749850 | ||
| The dim light melatonin onset as a marker for circadian phase position. | Q48948299 | ||
| A once-repeated study of nocturnal plasma melatonin patterns and sleep recordings in six normal young men. | Q49021341 | ||
| High performance plasma amyloid-β biomarkers for Alzheimer's disease. | Q50107488 | ||
| Slow-wave sleep: From the cell to the clinic. | Q50533703 | ||
| Decrease of ERK/MAPK overactivation in prefrontal cortex reverses early memory deficit in a mouse model of Alzheimer's disease. | Q50703189 | ||
| Functional CLOCK gene rs1554483 G/C polymorphism is associated with susceptibility to Alzheimer's disease in the Chinese population. | Q50895633 | ||
| Ultradian rhythm of basal corticosterone release in the female rat: dynamic interaction with the response to acute stress. | Q50910615 | ||
| BACE inhibitor bust in Alzheimer trial. | Q51117061 | ||
| Alzheimer amyloid hypothesis lives on. | Q51229653 | ||
| Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics. | Q52141889 | ||
| Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. | Q53274559 | ||
| Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker. | Q53285087 | ||
| Association between ARNTL (BMAL1) rs2278749 polymorphism T >C and susceptibility to Alzheimer disease in a Chinese population. | Q53372378 | ||
| Diurnal rhythmicity of the canonical clock genes Per1, Per2 and Bmal1 in the rat adrenal gland is unaltered after hypophysectomy. | Q53503947 | ||
| Impaired glucocorticoid production and response to stress in Arntl-deficient male mice. | Q54664042 | ||
| Increased Cortisol Levels in Aging and Alzheimer's Disease in Postmortem Cerebrospinal Fluid | Q59449663 | ||
| Alzheimer's disease | Q60313667 | ||
| Prolonged day length exposure improves circadian deficits and survival in a transgenic mouse model of Huntington's disease. | Q64930361 | ||
| Time course of EEG power density during long sleep in humans | Q68735238 | ||
| Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice | Q72044946 | ||
| Evidence for tryptophan hydroxylase and hydroxy-indol-O-methyl-transferase mRNAs in human blood platelets | Q73428039 | ||
| Chronic jet lag produces cognitive deficits | Q73514930 | ||
| Salivary melatonin as a circadian phase marker: validation and comparison to plasma melatonin | Q73894781 | ||
| The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to light | Q74287351 | ||
| Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response | Q81152624 | ||
| Hypothalamic regulation of sleep and arousal | Q81555262 | ||
| 2013 Alzheimer's disease facts and figures | Q86421768 | ||
| Slow-Wave Activity Enhancement to Improve Cognition | Q88301110 | ||
| ApoE and Aβ in Alzheimer's disease: accidental encounters or partners? | Q38190156 | ||
| Breakdown in REM sleep circuitry underlies REM sleep behavior disorder | Q38199785 | ||
| The gastrointestinal tract microbiome and potential link to Alzheimer's disease | Q38207585 | ||
| Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches | Q38209311 | ||
| Apolipoprotein E in Alzheimer's disease: an update | Q38211371 | ||
| Sleep and Alzheimer's disease | Q38213352 | ||
| Stress, arousal, and sleep. | Q38213884 | ||
| Stress, PTSD, and dementia | Q38219874 | ||
| Chronic stress as a risk factor for Alzheimer's disease | Q38245342 | ||
| β-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat | Q38254940 | ||
| Categorically distinct acute stressors elicit dissimilar transcriptional profiles in the paraventricular nucleus of the hypothalamus. | Q38352871 | ||
| Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial | Q38389742 | ||
| Immune attack: the role of inflammation in Alzheimer disease. | Q38492631 | ||
| The case for rejecting the amyloid cascade hypothesis. | Q38501528 | ||
| REM sleep and memory | Q38678906 | ||
| Brain Under Stress and Alzheimer's Disease | Q38683062 | ||
| The amyloid cascade hypothesis: are we poised for success or failure? | Q38802617 | ||
| Role of circadian rhythm and REM sleep for memory consolidation | Q38824167 | ||
| Amyloid-β induces sleep fragmentation that is rescued by fatty acid binding proteins in Drosophila | Q38851223 | ||
| The Gut-Brain Axis, BDNF, NMDA and CNS Disorders. | Q38935172 | ||
| Alzheimer's disease: Innate immunity gone awry? | Q38994852 | ||
| Mechanisms linking circadian clocks, sleep, and neurodegeneration | Q39019213 | ||
| The discovery of Alzheimer-causing mutations in the APP gene and the formulation of the "amyloid cascade hypothesis". | Q39068135 | ||
| Chronic intermittent hypoxia/reoxygenation facilitate amyloid-β generation in mice | Q39109895 | ||
| Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease | Q39257249 | ||
| Exaggerated phosphorylation of brain tau protein in CRH KO mice exposed to repeated immobilization stress. | Q39533185 | ||
| In vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysis | Q40276692 | ||
| Melatonin rhythmicity: effect of age and Alzheimer's disease | Q40609056 | ||
| Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides | Q41172424 | ||
| Amyloid β peptide directly impairs pineal gland melatonin synthesis and melatonin receptor signaling through the ERK pathway | Q41253356 | ||
| Diurnal variation in neuroendocrine response to stress in rats: plasma ACTH, beta-endorphin, beta-LPH, corticosterone, prolactin and pituitary cyclic AMP responses | Q41367187 | ||
| P921 | main subject | Alzheimer's disease | Q11081 |
| circadian rhythm | Q208353 | ||
| P304 | page(s) | 100133 | |
| P577 | publication date | 2018-10-17 | |
| P1433 | published in | Neurobiology of stress | Q27725976 |
| P1476 | title | Sleep and circadian rhythm disruption and stress intersect in Alzheimer's disease | |
| P478 | volume | 10 |
| Q90721583 | Analysis of Sociodemographic and Psychological Variables Involved in Sleep Quality in Nurses |
| Q92861516 | Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia |
| Q97530319 | Robust light-dark patterns and reduced amyloid load in an Alzheimer's disease transgenic mouse model |
| Q96136920 | The Critical Role of Nurr1 as a Mediator and Therapeutic Target in Alzheimer's Disease-related Pathogenesis |
| Q91650091 | The Links Between the Gut Microbiome, Aging, Modern Lifestyle and Alzheimer's Disease |
Search more.